<didl:DIDL xmlns:dcterms="http://purl.org/dc/terms/" xmlns:didl="urn:mpeg:mpeg21:2002:02-DIDL-NS" xmlns:dii="urn:mpeg:mpeg21:2002:01-DII-NS" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dip="urn:mpeg:mpeg21:2002:01-DIP-NS" xsi:schemaLocation="urn:mpeg:mpeg21:2002:02-DIDL-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/did/didl.xsd urn:mpeg:mpeg21:2002:01-DII-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/dii/dii.xsd urn:mpeg:mpeg21:2005:01-DIP-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/dip/dip.xsd" DIDLDocumentId="https://arxiv.universalpublishings.com/id/eprint/52939">
  <didl:Item>
    <didl:Descriptor>
      <didl:Statement mimeType="application/xml">
        <dii:Identifier>https://arxiv.universalpublishings.com/id/eprint/52939</dii:Identifier>
      </didl:Statement>
    </didl:Descriptor>
    <didl:Descriptor>
      <didl:Statement mimeType="application/xml">
        <dcterms:modified>2026-05-26T15:45:57Z</dcterms:modified>
      </didl:Statement>
    </didl:Descriptor>
    <didl:Component>
      <didl:Resource mimeType="application/xml" ref="https://arxiv.universalpublishings.com/cgi/export/eprint/52939/DIDL/arxiv-eprint-52939.xml"/>
    </didl:Component>
    <didl:Item>
      <didl:Descriptor>
        <didl:Statement mimeType="application/xml">
          <dip:ObjectType>info:eu-repo/semantics/descriptiveMetadata</dip:ObjectType>
        </didl:Statement>
      </didl:Descriptor>
      <didl:Component>
        <didl:Resource mimeType="application/xml">
          <oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
        <dc:relation>https://arxiv.universalpublishings.com/id/eprint/52939/</dc:relation>
        <dc:title>CLINICAL PHARMACOLOGY OF ANTIVIRAL DRUGS</dc:title>
        <dc:creator>oʻgʻli, Ergashev Asilbek Qudrat</dc:creator>
        <dc:creator>oʻgʻli, Abdunazarov Azimjon Alisher</dc:creator>
        <dc:creator>Yuldashevich, Chariev Muzaffar</dc:creator>
        <dc:description>This article discusses the clinical pharmacology, mechanism of action, time of action, types and composition of antiviral drugs. The article introduces new antiviral drugs being developed in the pharmaceutical industry, their pharmacotherapeutic groups, international non-patented names, and the country of manufacture. Nowadays, the need for antiviral drugs is increasing. Because it is the time when seasonal viral diseases and allergies are on the rise and immunity decreases to a certain extent. Therefore, we will get acquainted with the new anti-viral drugs included in the State Register.</dc:description>
        <dc:publisher>Center for Tech and Media Research</dc:publisher>
        <dc:date>2024-01-20</dc:date>
        <dc:type>Maqola</dc:type>
        <dc:type>NonPeerReviewed</dc:type>
        <dc:identifier>  oʻgʻli, Ergashev Asilbek Qudrat, oʻgʻli, Abdunazarov Azimjon Alisher, Yuldashevich, Chariev Muzaffar  (2024) CLINICAL PHARMACOLOGY OF ANTIVIRAL DRUGS.  Multidisciplinary Journal of Science and Technology.       </dc:identifier>
        <dc:relation>https://mjstjournal.com/index.php/mjst/article/view/731</dc:relation>
        <dc:relation>oai:ojs.pkp.sfu.ca:article/731</dc:relation>
        <dc:identifier>oai:ojs.pkp.sfu.ca:article/731</dc:identifier></oai_dc:dc>
        </didl:Resource>
      </didl:Component>
    </didl:Item>
    <didl:Item>
      <didl:Descriptor>
        <didl:Statement mimeType="application/xml">
          <dip:ObjectType>info:eu-repo/semantics/humanStartPage</dip:ObjectType>
        </didl:Statement>
      </didl:Descriptor>
      <didl:Component>
        <didl:Resource ref="https://arxiv.universalpublishings.com/id/eprint/52939/" mimeType="application/html"/>
      </didl:Component>
    </didl:Item>
  </didl:Item>
</didl:DIDL>